Clinical trial
Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in…
NCT00413920 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00413920 |
|---|---|
| Title | Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients |
| Official title | A Multicenter Randomized Open Label Study to Assess Efficacy and Safety of a Steroid Avoidance Regimen in Comparison to a Treatment With Steroids, in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS) 2.16 g/d for 6 Weeks and Cyclosporine Microemulsion, in de Novo Adult Renal Transplant… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | Enteric-coated mycophenolate sodium (EC-MPS), Prednisone |
| Enrollment | 222 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2009 |
| First posted | Dec 20, 2006 |
| Last update posted | Apr 21, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: